METHODS AND COMPOSITIONS FOR ALOPECIA TREATMENT USING FIBROBLASTS AND FIBROBLAST-DERIVED PRODUCTS

    公开(公告)号:WO2022251277A1

    公开(公告)日:2022-12-01

    申请号:PCT/US2022/030805

    申请日:2022-05-25

    Applicant: FIGENE, LLC

    Abstract: Disclosed herein are methods and compositions for treatment and prevention of alopecia, including alopecia areata. Aspects are directed to methods for stimulating or accelerating hair follicle regeneration. Certain aspects are directed to methods for treating alopecia areata comprising administration of fibroblasts and/or a fibroblast derived product to a subject suffering from alopecia areata. In some cases, a fibroblast derived product is conditioned media, exosomes, or apoptotic bodies from fibroblasts, formulated for topical use for treatment or prevention of alopecia areata.

    COMPOSITION FOR PREVENTING AND OR TREATING SKIN AND HAIR DISORDERS

    公开(公告)号:WO2022180651A1

    公开(公告)日:2022-09-01

    申请号:PCT/IT2021/000007

    申请日:2021-02-25

    Abstract: The present invention refers to a composition comprising one or more ellagitannin, one or more phenolic acid, one or more flavonoid, wherein: said one or more ellagitannin is selected from the group consisting of: castalagin, agrimoniin, vescalagin, and mixture thereof; said one or more phenolic acid is selected from the group consisting of: caffeic acid, ellagic acid, gallic acid, p-coumaric acid, ad mixture thereof; said one or more flavonoids are selected from the group consisting of: cyaniding, procyanidin, quercetin, catechin, epicatechin, kaempferol, delphinidin, pelargonidin, peonidin and mixture thereof. The present invention refers to a cosmetic use of the composition of the present invention for stimulating hair growth and/or preventing or treating hair loss and/or for skin anti-age effect. The present invention refers to the composition of the present invention for use in the prevention and/or treating of skin disorders and/or alopecia. The present invention refers to the composition of the present invention, wherein said composition is in a form for oral administration or topic application.

Patent Agency Ranking